Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database
Colorectal cancer (CRC) is the third most common cancer in the world, with an average 5-year overall survival (OS) rate of approximately 60% [...].
Authors
- Felicia Gabriela Gligor (ORCID: https://orcid.org/0000-0003-3167-9864)
- Vlad Vornicu
- Andreea Loredana Vonica-Țincu (ORCID: https://orcid.org/0000-0001-6362-4302)
- Claudiu Morgovan (ORCID: https://orcid.org/0000-0003-2730-8729)
- Adina Frum (ORCID: https://orcid.org/0000-0003-4874-0430)
- Stéliana Ghibu (ORCID: https://orcid.org/0000-0003-2247-4613)
- Anca Butucă (ORCID: https://orcid.org/0000-0003-1540-641X)
- Remus Călin Cipăian
- Carmen Maximiliana Dobrea (ORCID: https://orcid.org/0000-0002-9913-1750)
- Florina Batâr (ORCID: https://orcid.org/0000-0002-1147-9251)
- Manuela Pumnea
- Razvan Constantin Vonica
- Aliteia-Maria Pacnejer
Institutions
- Lucian Blaga University of Sibiu (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Publication Details
- Journal
- Cancers
- Published
- 2025-02-16
- DOI
- https://doi.org/10.3390/cancers17040663
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Universitatea "Lucian Blaga" din Sibiu